Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,224,395
-
Total 13F shares
-
108,375,993
-
Share change
-
+6,761,352
-
Total reported value
-
$1,844,441,951
-
Put/Call ratio
-
299%
-
Price per share
-
$17.01
-
Number of holders
-
214
-
Value change
-
+$102,159,920
-
Number of buys
-
115
-
Number of sells
-
120
Institutional Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q2 2025
As of 30 Jun 2025 Beam Therapeutics Inc. - COMMON STOCK (BEAM) had 214 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 108,375,993 shares of stock of the company.
Largest 10 holders included FMR LLC, FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ARK Investment Management LLC, BlackRock, Inc., Sumitomo Mitsui Trust Group, Inc., Nikko Asset Management Americas, Inc., ARCH Venture Management, LLC, STATE STREET CORP, and Bellevue Group AG.
This table shows 214 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.